Phase 3 Lupus Nephritis Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Lupus Nephritis
Novartis Pharmaceuticals462 enrolled188 locationsNCT05126277
Recruiting
Phase 3
Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
Lupus Nephritis
Novartis Pharmaceuticals315 enrolled25 locationsNCT06711887
Recruiting
Phase 3
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
Systemic Lupus Erythematosus (SLE)Lupus Nephritis
Assistance Publique - Hôpitaux de Paris196 enrolled1 locationNCT04702256
Recruiting
Phase 3
Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children
Lupus Nephritis
Guangzhou Women and Children's Medical Center50 enrolled1 locationNCT06904729
Recruiting
Phase 3
A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis
Lupus Nephritis
Qilu Pharmaceutical Co., Ltd.270 enrolled10 locationsNCT06406205
Recruiting
Phase 3
Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis
Lupus Nephritis patients
Royal Brisbane32 enrolled1 locationACTRN12611000798965